Cytek Biosciences, Inc. (CTKB) shareholders
Close on Nov 17, 2026Market cap $740.91MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 9,356,551 | 7.20% | 13G (passive) amendment | Jun 30, 2026 |
| Millennium Group Management LLC Joint filing with Millennium Management LLC (7.20%), Israel A. Englander (7.20%) and 1 more | 9,338,010 | 7.20% | 13G (passive) amendment | Jun 30, 2026 |
| Boston Partners | 7,635,145 | 5.91% | 13G (passive) | Jun 30, 2026 |
| Israel A. Englander Joint filing with Millennium Management LLC (5.60%), Millennium Group Management LLC (5.60%) | 7,281,488 | 5.60% | 13G (passive) amendment | Sep 30, 2026 |
| Topline Capital Management, LLC Joint filing with Collin McBirney (5.30%), Topline Capital Partners, LP (5.30%) | 6,780,847 | 5.30% | 13G (passive) | Sep 25, 2025 |
| Hillhouse Investment Management, Ltd. | 6,657,030 | 5.10% | 13G (passive) | Sep 30, 2024 |
| Millennium Management LLC Joint filing with Millennium Group Management LLC (5.20%), Israel A. Englander (5.20%) | 6,638,827 | 5.20% | 13G (passive) | Apr 2, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CTKB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,578,643 | 7.37% | $42.43M | −7,428,626 | 0.00% |
| Millennium Management LLC | 9,338,010 | 7.18% | $41.37M | +3,046,212 | 0.01% |
| Boston Partners | 7,660,943 | 5.89% | $33.94M | +1,858,170 | 0.03% |
| Hhlr Advisors, Ltd. | 6,657,030 | 5.12% | $29.49M | – | 3.54% |
| Topline Capital Management, LLC | 6,283,450 | 4.83% | $27.84M | −781,031 | 7.22% |
| Vanguard Capital Management LLC | 4,939,597 | 3.80% | $21.88M | +176,693 | 0.00% |
| Geode Capital Management, LLC | 3,059,573 | 2.35% | $13.56M | +225,618 | 0.00% |
| Dimensional Fund Advisors LP | 2,616,257 | 2.01% | $11.59M | −47,072 | 0.00% |
| State Street Corp | 2,566,121 | 1.97% | $11.37M | −1,557,627 | 0.00% |
| Goldman Sachs Group Inc | 2,167,515 | 1.67% | $9.60M | −177,220 | 0.00% |
| Royce & Associates LP | 2,081,579 | 1.60% | $9.22M | +439,211 | 0.07% |
| Russell Investments Group, Ltd. | 1,511,315 | 1.16% | $6.70M | +151,415 | 0.01% |
| Acadian Asset Management LLC | 1,376,048 | 1.06% | $6.09M | +977,060 | 0.01% |
| Bank Of America Corp /De/ | 1,315,332 | 1.01% | $5.83M | +306,278 | 0.00% |
| Vanguard Portfolio Management LLC | 1,141,592 | 0.88% | $5.06M | −1,170,266 | 0.00% |
| Charles Schwab Investment Management Inc | 1,073,253 | 0.83% | $4.75M | −31,348 | 0.00% |
| Northern Trust Corp | 1,003,294 | 0.77% | $4.44M | −1,899 | 0.00% |
| Hrt Financial LP | 997,769 | 0.77% | $4.42M | +583,717 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 973,833 | 0.75% | $4.31M | +653,924 | 0.00% |
| Jane Street Group, LLC | 906,162 | 0.70% | $4.01M | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 155 | 82M | 62.7% | 29 / 45 | 65 / 37 | 15M | 19M |
| Q1 2026 | 165 | 85M | 65.4% | 24 / 68 | 51 / 11 | 14M | 4M |
| Q4 2025 | 155 | 82M | 63.1% | 21 / 52 | 61 / 15 | 11M | 10M |
| Q3 2025 | 153 | 80M | 61.8% | 20 / 63 | 52 / 24 | 11M | 10M |
| Q2 2025 | 158 | 79M | 61.1% | 25 / 65 | 47 / 27 | 10M | 8M |
| Q1 2025 | 160 | 78M | 59.7% | 30 / 50 | 64 / 21 | 9M | 8M |
| Q4 2024 | 152 | 77M | 59.4% | 32 / 56 | 43 / 16 | 6M | 4M |
| Q3 2024 | 136 | 76M | 58.1% | 20 / 66 | 32 / 12 | 21M | 5M |
| Q2 2024 | 129 | 77M | 59.1% | 21 / 55 | 41 / 16 | 6M | 12M |
| Q1 2024 | 125 | 82M | 63.4% | 24 / 43 | 36 / 4 | 4M | 1M |
| Q4 2023 | 105 | 80M | 61.5% | 18 / 44 | 29 / 19 | 6M | 3M |
| Q3 2023 | 106 | 77M | 59.6% | 18 / 54 | 23 / 13 | 9M | 8M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
163 funds held CTKB in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CTKB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,525,848 | 2.71% | $15.62M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,164,683 | 2.43% | $14.02M | 0.02% | Jun 30, 2026 |
| Column Small Cap Select Fund | 2,378,955 | 1.83% | $9.97M | 0.53% | May 31, 2026 |
| Fidelity Small Cap Index Fund | 1,329,842 | 1.02% | $5.61M | 0.02% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,300,320 | 1.00% | $5.76M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 1,107,950 | 0.85% | $4.91M | 0.03% | Jun 30, 2026 |
| WPG Partners Select Small Cap Value Fund | 945,719 | 0.73% | $3.96M | 1.69% | May 31, 2026 |
| iShares Biotechnology ETF | 833,257 | 0.64% | $3.69M | 0.04% | Jun 30, 2026 |
| Goldman Sachs Small Cap Value Insights Fund | 639,133 | 0.49% | $2.70M | 0.20% | Jul 31, 2026 |
| Vanguard Russell 2000 Index Fund | 602,711 | 0.46% | $2.53M | 0.01% | May 31, 2026 |
| Royce Micro-Cap Fund | 572,392 | 0.44% | $2.54M | 0.59% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 567,467 | 0.44% | $2.38M | 0.01% | May 31, 2026 |
| U.S. Small Cap Portfolio | 566,763 | 0.44% | $2.39M | 0.01% | Jul 31, 2026 |
| Schwab U.S. Small-Cap ETF | 529,904 | 0.41% | $2.22M | 0.01% | May 31, 2026 |
| Fidelity Enhanced Small Cap Core ETF | 493,884 | 0.38% | $2.19M | 0.04% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ming Yan | CHIEF TECHNOLOGY OFFICER, Director | 4,821,870 | 3.71% | Aug 20, 2026 |
| Wenbin Jiang | PRESIDENT AND CEO, Director | 8,248,585 | 6.35% | Aug 20, 2026 |
| Ilan Feuchtwang | Chief Legal Officer, Secretary | – | – | Nov 12, 2026 |
| William D. McCombe | Chief Financial Officer | 115,386 | 0.09% | Aug 20, 2026 |
| Valerie Barnett | CHIEF LEGAL OFFICER | 139,315 | 0.11% | May 20, 2026 |
| Philippe Busque | SVP, GLOBAL SALES AND SERVICES | 36,711 | 0.03% | May 20, 2026 |
| Allen Poirson | SVP BUS. AND CORP. DEV. | 59,981 | 0.05% | Nov 20, 2024 |
| Richard Chin | Director | 28,499 | 0.02% | Aug 20, 2026 |
| Michael Holder | Director | 62,875 | 0.05% | Aug 20, 2026 |
| Glenn P. Muir | Director | 3,086 | 0.00% | Aug 20, 2026 |
| Jack Ball | Director | 86,678 | 0.07% | Jun 12, 2026 |
| Deborah J. Neff | Director | 59,679 | 0.05% | Jun 12, 2026 |
| Vera Imper | Director | 59,679 | 0.05% | Jun 12, 2026 |
| Don M. Hardison | Director | 15,706 | 0.01% | Jun 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William D. McCombe Chief Financial Officer | Aug 18, 2026 | Tax withholding | −2,111 | $4.67 | $9.86K | 115,386 |
| William D. McCombe Chief Financial Officer | Aug 18, 2026 | Option exercise | +6,320 | – | – | 117,497 |
| William D. McCombe Chief Financial Officer | Aug 18, 2026 | Tax withholding | −4,392 | $4.67 | $20.51K | 124,045 |
| William D. McCombe Chief Financial Officer | Aug 18, 2026 | Option exercise | +16,049 | – | – | 140,094 |
| William D. McCombe Chief Financial Officer | Aug 18, 2026 | Tax withholding | −5,401 | $4.67 | $25.22K | 134,693 |
| William D. McCombe Chief Financial Officer | Aug 18, 2026 | Option exercise | +13,051 | – | – | 128,437 |
| Glenn P. Muir Director | Aug 18, 2026 | Option exercise | +3,086 | – | – | 3,086 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Tax withholding | −3,463 | $4.67 | $16.17K | 4,821,870 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Option exercise | +14,220 | – | – | 4,825,333 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Tax withholding | −1,501 | $4.67 | $7.01K | 4,811,113 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Option exercise | +6,162 | – | – | 4,812,614 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Tax withholding | −1,346 | $4.67 | $6.29K | 4,806,452 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Option exercise | +5,525 | – | – | 4,807,798 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Tax withholding | −1,778 | $4.67 | $8.30K | 4,802,273 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Aug 18, 2026 | Option exercise | +7,363 | – | – | 4,804,051 |
| Michael Holder Director | Aug 18, 2026 | Option exercise | +2,181 | – | – | 62,875 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Option exercise | +57,212 | – | – | 5,581,985 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Tax withholding | −7,062 | $4.67 | $32.98K | 5,524,773 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Tax withholding | −20,956 | $4.67 | $97.86K | 5,561,029 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Option exercise | +29,002 | – | – | 5,531,835 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Tax withholding | −5,382 | $4.67 | $25.13K | 5,502,833 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Option exercise | +22,100 | – | – | 5,508,215 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Tax withholding | −2,869 | $4.67 | $13.40K | 5,486,115 |
| Wenbin Jiang PRESIDENT AND CEO, Director | Aug 18, 2026 | Option exercise | +11,781 | – | – | 5,488,984 |
| Richard Chin Director | Aug 18, 2026 | Option exercise | +6,107 | – | – | 28,499 |
| Ming Yan CHIEF TECHNOLOGY OFFICER, Director | Jun 12, 2026 | Gift | −135,892 | – | – | 4,796,688 |
| Michael Holder Director | Jun 10, 2026 | Option exercise | +43,973 | – | – | 60,694 |
| Deborah J. Neff Director | Jun 10, 2026 | Option exercise | +43,973 | – | – | 59,679 |
| Vera Imper Director | Jun 10, 2026 | Option exercise | +43,973 | – | – | 59,679 |
| Jack Ball Director | Jun 10, 2026 | Option exercise | +43,973 | – | – | 86,678 |
| Richard Chin Director | May 18, 2026 | Option exercise | +6,107 | – | – | 22,392 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Tax withholding | −1,850 | $3.55 | $6.57K | 139,315 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Option exercise | +9,435 | – | – | 153,398 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Tax withholding | −2,602 | $3.55 | $9.24K | 143,963 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Option exercise | +7,250 | – | – | 146,565 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Tax withholding | −3,386 | $3.55 | $12.02K | 150,012 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Option exercise | +5,156 | – | – | 141,165 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Tax withholding | −881 | $3.55 | $3.13K | 136,009 |
| Valerie Barnett CHIEF LEGAL OFFICER | May 18, 2026 | Option exercise | +2,454 | – | – | 136,890 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Tax withholding | −15,009 | $3.55 | $53.28K | 5,477,203 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Option exercise | +14,733 | – | – | 5,443,357 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Tax withholding | −1,913 | $3.55 | $6.79K | 5,428,624 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Option exercise | +7,854 | – | – | 5,430,537 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Tax withholding | −3,588 | $3.55 | $12.74K | 5,439,769 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Option exercise | +38,141 | – | – | 5,492,212 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Tax withholding | −5,032 | $3.55 | $17.86K | 5,454,071 |
| Wenbin Jiang PRESIDENT AND CEO, Director | May 18, 2026 | Option exercise | +19,334 | – | – | 5,459,103 |
| William D. McCombe Chief Financial Officer | May 18, 2026 | Tax withholding | −3,122 | $3.55 | $11.08K | 104,317 |
| William D. McCombe Chief Financial Officer | May 18, 2026 | Option exercise | +6,320 | – | – | 101,007 |
| William D. McCombe Chief Financial Officer | May 18, 2026 | Tax withholding | −2,268 | $3.55 | $8.05K | 98,739 |
| William D. McCombe Chief Financial Officer | May 18, 2026 | Tax withholding | −3,839 | $3.55 | $13.63K | 111,177 |
| William D. McCombe Chief Financial Officer | May 18, 2026 | Option exercise | +10,699 | – | – | 115,016 |
| William D. McCombe Chief Financial Officer | May 18, 2026 | Option exercise | +8,700 | – | – | 107,439 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Option exercise | +1,024 | – | – | 36,711 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Tax withholding | −1,424 | $3.55 | $5.06K | 43,466 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Option exercise | +5,551 | – | – | 44,890 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Tax withholding | −263 | $3.55 | $934 | 36,448 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Option exercise | +1,473 | – | – | 37,921 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Tax withholding | −620 | $3.55 | $2.20K | 39,339 |
| Philippe Busque SVP, GLOBAL SALES AND SERVICES | May 18, 2026 | Option exercise | +2,416 | – | – | 39,959 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cytek Biosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,910 shares on Sep 10, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Philippe Busque Officer | Sep 2, 2026 | 31,666 | $146.52K | Sep 2, 2026 | Stock Option Exercise |
| Ming Yan Officer | Apr 9, 2024 | 40,000 | $268.00K | Apr 9, 2024 | Founders Shares |
| Ming Yan Officer | Mar 18, 2024 | 40,000 | $278.00K | Mar 18, 2024 | Founders Shares |
| Ming Yan Officer | Dec 19, 2023 | 20,000 | $184.20K | Dec 19, 2023 | Founders Shares |
| David Vrane Officer | Nov 15, 2023 | 12,000 | $65.64K | Nov 15, 2023 | Founders Shares |
| Patrik Jeanmonod Officer | Oct 24, 2023 | 9,000 | $41.58K | Oct 24, 2023 | Previously Exercised Stock Options |
| Ming Yan Officer | Oct 19, 2023 | 40,000 | $193.60K | Oct 19, 2023 | Restricted Stock Units |
| Wenbin Jiang Officer | Sep 7, 2023 | 60,000 | $413.40K | Sep 7, 2023 | Founders Shares |
| Ming Yan Officer | Aug 21, 2023 | 40,000 | $338.40K | Aug 21, 2023 | Founders Shares |
| David Vrane Officer | Aug 14, 2023 | 12,000 | $112.68K | Aug 14, 2023 | Founders Shares |
| Patrik Jeanmonod Officer | Jul 24, 2023 | 9,000 | $80.10K | Jul 24, 2023 | Previously Exercised Stock Options |
| Ming Yan Officer | Jun 20, 2023 | 40,000 | $334.00K | Jun 20, 2023 | Founders Shares |
| Wenbin Jiang Officer | Jun 7, 2023 | 60,000 | $489.60K | Jun 7, 2023 | Founders Shares |
| David Vrane Officer | May 15, 2023 | 12,000 | $89.88K | May 15, 2023 | Founders Shares |
| Wenbin Jiang Director, Officer | May 8, 2023 | 20,000 | $238.40K | May 8, 2023 | Founders Shares |
See a number that looks wrong?